Description: Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.
Home Page: www.genedriveplc.com
GDR Technical Analysis
The CTF Building
Manchester,
M13 9XX
United Kingdom
Phone:
44 16 1989 0245
Officers
| Name | Title |
|---|---|
| Mr. David Budd | CEO & Exec. Director |
| Mr. Russell John Shaw | Chief Financial Officer & Director |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 11.5473 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.6081 |
| Price-to-Sales TTM: | 184.1405 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 40 |